Determination of catecholamines and their metabolites by radioisotopic techniques, value in pharmacology and physiopathology

At present the only way to estimate catecholamines and similar compounds at concentrations between 10 and 100 femtomoles is by the use of radioenzymatic techniques. Such methods are all based in practice on the enzymatic transformation of these substrates, in the presence of labelled S-adenosylmethionine, under the action of catechol-O-methyltrans-ferase (COMT) or phenylethanol-amine-N-methyltransferase (PNMT), which means that molecules suitable for such determinations must possess either a catechol group (catecholamines, dihydroxyphenylalanine, dihydroxyphenylacetic acid) or a phenylethanolamine group (noradrenaline, methoxynoradrenaline). At present the largest number of molecules may be estimated by methods based on the principle of O-methylation by COMT. The main processes described in the literature are examined, with special reference to the proposed means of solving problems which arise at various stages of the determination, mention is made of the many difficulties inherent in this kind of manipulation and of the limits to be expected of these tests. The immunological aspect of quantitative research on catecholamines and their derivatives is mentioned, work in this direction at present being based on radioimmunology. As a practical illustration of the many methodological studies mentioned, the application of radioisotopic techniques to in vitro exploration of the catecholamine metabolism is discussed; the contribution of these new techniques is shown particularly in the physiopathological study of certain metabolic disorders observed in man, in the pharmacodynamic study of certain molecules and in experimental studies on the central nervous system